Yota Hayama

Green Culture, Inc. is a Japanese food tech company that develops and sells plant-based food products. The company is based in Tokyo, Japan. The company's mission is centered on promoting health and providing new food options to the world. The company has developed a plant meat called "green meat" made from soybeans and peas, which is a more delicious alternative to meat and soy meat. The company was founded in 2011 by Satoshi Kaneda, who has been the CEO since then.

SoPros, Inc. is a Japanese startup company founded in May 2018 by Makoto Watanabe. The company is based in Tsukuba, Japan. SoPros aims to enter the healthcare market by utilizing high-specific micro-algae improvement technology through cutting-edge biotechnology. The company's goal is to contribute to the world healthcare by developing in-house stocks derived from oanti okitorium and micro-algae technology. The CEO is Shoichi Ikemizu.

Green Culture, Inc. is a Japanese food tech company that develops and sells plant-based food products. The company is based in Tokyo, Japan. The company's mission is centered on promoting health and providing new food options to the world. The company has developed a plant meat called "green meat" made from soybeans and peas, which is a more delicious alternative to meat and soy meat. The company was founded in 2011 by Satoshi Kaneda, who has been the CEO since then.

Green Culture, Inc. is a Japanese food tech company that develops and sells plant-based food products. The company is based in Tokyo, Japan. The company's mission is centered on promoting health and providing new food options to the world. The company has developed a plant meat called "green meat" made from soybeans and peas, which is a more delicious alternative to meat and soy meat. The company was founded in 2011 by Satoshi Kaneda, who has been the CEO since then.

SoPros, Inc. is a Japanese startup company founded in May 2018 by Makoto Watanabe. The company is based in Tsukuba, Japan. SoPros aims to enter the healthcare market by utilizing high-specific micro-algae improvement technology through cutting-edge biotechnology. The company's goal is to contribute to the world healthcare by developing in-house stocks derived from oanti okitorium and micro-algae technology. The CEO is Shoichi Ikemizu.